U.S. Court of Appeals for the Federal Circuit, 2026

Msn Laboratories Private Ltd. v. Bausch Health Ireland Ltd.

Msn Laboratories Private Ltd. v. Bausch Health Ireland Ltd.
U.S. Court of Appeals for the Federal Circuit · Decided April 14, 2026
Msn Laboratories Private Ltd. v. Bausch Health Ireland Ltd.

Opinion

Case: 26-1595 Document: 8 Page: 1 Filed: 04/14/2026

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

MSN LABORATORIES PRIVATE LTD., MSN

PHARMACEUTICALS, INC.,

Appellants v.

BAUSCH HEALTH IRELAND LTD.,

Appellee ______________________

2026-1595 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2022- 00722 and IPR2023-00016. ______________________

ON MOTION ______________________

ORDER

Upon consideration of appellants’ unopposed motion to voluntarily dismiss this appeal pursuant to Federal Rule of Appellate Procedure 42(b), and the parties’ agreement as to the allocation of costs,

IT IS ORDERED THAT: (1) The motion is granted. The appeal is dismissed. Case: 26-1595 Document: 8 Page: 2 Filed: 04/14/2026

2 MSN LABORATORIES PRIVATE LTD. v. BAUSCH HEALTH IRELAND LTD.

(2) Each side shall bear its own cost.

FOR THE COURT

April 14, 2026

Date

ISSUED AS A MANDATE: April 14, 2026

Case-law data current through September 30, 2026. Source: CourtListener bulk data.